During the past decade, Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 17 clinical trials were completed, i.e. on average, 89.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE" #1 sponsor was "VA Office of Research and Development" with 16 trials, followed by "US Department of Veterans Affairs" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 6 trials sponsored and "University of Nebraska" with 6 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "American Diabetes Association" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "University of Nebraska" with 3 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE" are "Type 2 Diabetes Mellitus" (6 trials), "Lung Cancer" (5 trials), "Apathy" (3 trials), "Chronic Obstructive Pulmonary Disease" (3 trials) and "Peripheral Arterial Disease" (3 trials). Many other conditions were trialed in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE" in a lesser frequency.

Most popular intervention types in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE" are "Drug" (44 trials), "Other" (11 trials), "Procedure" (7 trials), "Biological" (6 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "cyclophosphamide" (3 trials), "Rosiglitazone" (2 trials), "Tirzepatide" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE" are 67 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 15 trials that are defined as “Not Applicable".